Sub Banner Image

Abeona Therapeutics Wins FDA Approval For First-of-Its-Kind Gene Therapy

Market Impact

Vandana Singh

·

April 29, 2025

·

Benzinga

FDA approves Zevaskyn as the first cell-based gene therapy for RDEB wounds after strong results in pivotal and long-term studies.

read more

More from

Benzinga

More

Market Impact

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.